BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Avagliano C, Coretti L, Lama A, Pirozzi C, De Caro C, De Biase D, Turco L, Mollica MP, Paciello O, Calignano A, Meli R, Lembo F, Mattace Raso G. Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate. Int J Mol Sci 2022;23:6367. [PMID: 35742813 DOI: 10.3390/ijms23126367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Xu S, Qian Y, Mo C, Ai P, Yang X, Xiao Q. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota. Front Aging Neurosci 2023;15:1099018. [PMID: 36761177 DOI: 10.3389/fnagi.2023.1099018] [Reference Citation Analysis]
2 Cavaliere G, Catapano A, Trinchese G, Cimmino F, Penna E, Pizzella A, Cristiano C, Lama A, Crispino M, Mollica MP. Butyrate Improves Neuroinflammation and Mitochondrial Impairment in Cerebral Cortex and Synaptic Fraction in an Animal Model of Diet-Induced Obesity. Antioxidants (Basel) 2022;12. [PMID: 36670866 DOI: 10.3390/antiox12010004] [Reference Citation Analysis]
3 Varesi A, Campagnoli LIM, Fahmideh F, Pierella E, Romeo M, Ricevuti G, Nicoletta M, Chirumbolo S, Pascale A. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment. Int J Mol Sci 2022;23:12289. [PMID: 36293176 DOI: 10.3390/ijms232012289] [Reference Citation Analysis]
4 Xu RC, Miao WT, Xu JY, Xu WX, Liu MR, Ding ST, Jian YX, Lei YH, Yan N, Liu HD. Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice. Nutrients 2022;14:4163. [PMID: 36235813 DOI: 10.3390/nu14194163] [Reference Citation Analysis]